Drawing for SANGSTAT

USPTO serial 74241026

SANGSTAT

Reviewed by CopyMark Law Group

Reg. 1858296Status 710
Filing date
Status date
Registration date
Oct 18, 1994
Examiner
LEVINE, HOWARD B
Law office
GENERIC WEB UPDATE

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with SANGSTAT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

ROCHELLE ALPERT

RICHARD D ALLISON GENZYME CORPORATION15 PLEASANT ST CONNECTORLEGAL DEPTFRAMINGHAM, MA 1701

Goods and services

ClassDescriptionStatusFirst use
001[ chemical preparations for in vitro HLA antigen typing, histocompatibility testing, and monitoring of immunological parameters therapeutic drug monitoring and blood banking for research laboratory use; reagents for antigen/antibody testing of chemicals and immunological parameters for use in analytical and research laboratories ]SECTION 8 - CANCELLED—
005therapeutic pharmaceutical preparations for use in organ transplantation, immune modulation, cancer, auto-immune diseasesSECTION 8 - CANCELLEDJan 20, 1992
009[ biomedical research apparatus; namely, microtiter strips and cartridges containing reagents for use in transplanation, virology, hormonology, immunogenics, cancer diagnosis and research, therapeutic drug monitoring, and blood banking, immaging devices for quantitation of reaction levels in analytic cartridges ]SECTION 8 - CANCELLED—
010[ biomedical apparatus for diagnosis; namely, microtiter strips and cartridges containing reagents for use in transplanation, virology, hormonology, immunogenics, cancer diagnosis and research, therapeutic drug monitoring, and blood banking, immaging devices for quantitation of reaction levels in analytic cartridges ]SECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 12, 2015ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Jun 5, 2015C8.TCANCELLED SEC. 8 (10-YR)—
Jul 20, 2007CFITCASE FILE IN TICRS—
Jul 26, 2004TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 21, 2004TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 13, 2004RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Jan 13, 200489AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Nov 3, 200389AFREGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED—
Nov 3, 2003E89RTEAS SECTION 8 & 9 RECEIVED—
Mar 2, 2001C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Oct 24, 2000815FREGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED—
Oct 18, 1994R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 26, 1994PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 24, 1994NPUBNOTICE OF PUBLICATION—
May 9, 1994CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 29, 1994CNEAEXAMINER'S AMENDMENT MAILED—
Apr 13, 1994CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 7, 1994CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 2, 1993CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 18, 1993REINREINSTATED—
Jul 12, 1993CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 1, 1993ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 24, 1992CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 1992DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance